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Methods: Thirty-six Ldlr -/-Apob 100/100 mice were fed a high-fat diet (HFD) for 12 weeks and then allocated to receive a HFD (n=13), chow diet (Chow, n=12), or HFD with added atorvastatin (HFD+A, n=11), for another 12 weeks. In addition to aortic histopathology, [
18 F]FDG uptake was studied in vivo using PET/computed tomography (CT), and ex vivo by gamma counting of excised aorta.
Results: Total cholesterol levels were lower in the Chow and HFD+A groups than in the HFD group (10±3.2, 23±4.9 and 34±9.2 mmol/l, respectively), with the Chow group also showing a lower plaque burden and 
Introduction
Inflammation plays a central role in the development of atherosclerosis and its complications, with macrophages being the most prominent inflammatory cells in atherosclerotic plaques [1] . Statin therapy can inhibit the progression of atherosclerotic plaques [2] and reduce the cardiovascular risk [3] . The main mechanism of action of statins is to reduce the blood cholesterol concentration by inhibiting 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase, an enzyme that catalyzes endogenous cholesterol synthesis in the liver. However, statins have biological actions that are independent of cholesterol lowering, referred to as pleiotropic effects [4] . The reduction of cardiovascular risk is greater than expected on the basis of cholesterol reduction alone [5] , and has been evident even before cholesterol lowering [6, 7] . This is partly attributed to plaque-stabilizing effects related to the inhibition of the inflammatory response [8] [9] [10] .
However, the contributions of pleiotropic effects of statins on cardiovascular risk reduction in individuals with elevated systemic inflammatory markers is very difficult to study in clinical trials, because cholesterol lowering itself is strongly atheroprotective [11, 12] .
Positron emission tomography/computed tomography (PET/CT) is a translational imaging method utilized in clinical studies and animal research. PET/CT imaging using 2-deoxy-2-[ [13] .
The responsiveness of LDL receptor-deficient (Ldlr -/-) mice to statin therapy is limited, as the cellular intake of cholesterol cannot be increased via the LDL receptor [16] [17] [18] . Ldlr -/-mice expressing only apolipoprotein
-/-mice, since the lipoprotein clearance via Ldlr-related proteins (LRPs) is also impaired [19, 20] .
These mice have a cholesterol profile resembling human familial hypercholesterolemia, and they develop extensive atherosclerosis in the aorta [19, 21, 22] . Therefore, to further study the possible cholesterolindependent effects of statin therapy on vascular inflammation in atherosclerosis, we used histology and 
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7 resolution CT was performed to visualize the blood vessels. The image reconstruction parameters were similar to those previously described [24] . The PET/CT image analysis was performed using Carimas 2.9 software (Turku PET Centre, Turku, Finland). Uptake was evaluated by defining regions of interest (ROIs) in the aorta, blood, myocardium, and muscle, using the contrast-enhanced CT images. The aortic ROI was placed in the arch, avoiding myocardial spillover. Blood radioactivity concentration was analyzed from the vena cava. Radioactivity concentrations were measured as mean standardized uptake values (SUV): (Tissue radioactivity/tissue volume)/(total injected radioactivity/mouse weight). Uptake in the aorta was normalized by calculating the target-to-background ratio (TBR) by dividing the aortic arch SUV by the blood SUV.
Ex vivo measurements and ARG
After imaging, the mice were sacrificed at 100-min post-injection by cardiac puncture and cervical dislocation. For the mice not imaged in vivo, [ Radioactivity concentrations in organs and blood were calculated as SUV: (tissue radioactivity/tissue weight)/(total injected radioactivity/mouse weight). The aortic TBR was defined as described above.
Digital ARG for longitudinal aortic cryosections was performed following methods described in a previous study [23] . The cryosections were placed under radiation-sensitive imaging plate for 4 hours and the plate was then scanned with a phosphoimager (Fuji BAS-5000 or FLA-5100, Fuji Photo Film Co., Ltd., Tokyo, Japan) to obtain digital ARG images. The ARG analysis was performed with Tina 2.1 software (Raytest isotopemessgeräte, GmbH, Straubenhardt, Germany). The ROIs in ARG images were defined in plaques (at M A N U S C R I P T Paraffin-embedded aortic roots were cut to serial 5 µm sections at the level of the coronary ostia and stained with Movat's pentachrome, or with anti-Mac-3 antibody for macrophages [24] . The total area of intima and the Mac-3-positive area were measured using ImageJ software (NIH, Bethesda, MD, USA).
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The levels of total cholesterol, plaque burden, and macrophages were compared with the measured aortic [25] . Then, 11 mice per group would be needed to detect 20 % difference in the uptake at 80 % probability with the alpha value of 0.05.
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Results
At the baseline age of 20 weeks, all the mouse groups showed similar characteristics ( Table 1 ). The food consumption (g/mouse/day) was on average 2.6±0.39 in the HFD group, 3.1±0.36 in the Chow group, and 2.3±0.51 in the HFD+A group, with the mean energy intake being 12±1.8, 11±1.3, and 10±2.3
kcal/mouse/day, respectively (the differences between groups were not significant). In the HFD+A group, the average intake of atorvastatin was 8.2±1.4 mg/kg per day. Five mice in the HFD group and one mouse in the HFD+A group were terminated before the end of the study and excluded from the dataset, according to the pre-defined criteria described in the methods section. The final group sizes were 13, 12, and 11 for the HFD, Chow, and HFD+A groups, respectively. As the results contained no indications of gender differences, the results from male and female mice were pooled.
Plasma lipids and biomarkers
Compared with baseline levels, plasma total cholesterol was lowered by 71% (from 35 to 10 mmol/l) in the Chow group and 39% (from 37 to 23 mmol/l) in the HFD+A group, whereas cholesterol levels in the HFD group were sustained (from 35 to 34 mmol/l; Table 1 , Supplemental Fig. 1 ). At the end of the study, the differences in total cholesterol levels were significant between all groups (p<0.001). Leptin levels were lower in the Chow group than in the HFD group. No significant differences between groups were observed in the levels of triglycerides, IL-6, MCP-1, or insulin.
Plaque burden and inflammation
Histology was evaluated in the aortic roots (Fig. 1) . The area of intima was 34% less (0.76±0.27 vs. Table 2 ).
Uptake in the HFD+A group (TBR: 3.9±1.8) was between the other groups, but was not significantly different to either of them.
The ARG (Fig. 3) showed lower count densities in the Chow group than in the HFD group in both the plaque 
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 13 Discussion
The main finding of the study was that oral atorvastatin intervention had no significant effect on [19, 20, 27] . Definition of the exact mechanisms underlying cholesterol lowering is beyond the scope of this study.
Statin treatment in Ldlr -/-mice has generally led to reduced atherosclerotic lesion size, regardless of the effects on plasma cholesterol levels [16, 17, 28, 29] . Reduction of the inflammatory process occurring in neointimal thickening in a vascular injury model has been observed with simvastatin treatment [17] , but the effects of statins on atherosclerotic inflammation induced by HFD feeding in Ldlr -/-mice are not well known. Our results are somewhat contradictory to the previous studies, as atorvastatin treatment showed no effect on plaque burden or macrophage content. This might be related to the duration and timing of the interventions, as large inflamed atherosclerotic lesions were already present in the Ldlr -/-Apob 100/100 mice at baseline [23] . The dose of atorvastatin was selected to roughly correspond to the high-dose therapy in M A N U S C R I P T
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14 humans, while taking into account the high baseline cholesterol level in the mice [16] . The choice of statin may also have a role, as the pharmacokinetic properties of different statins, such as lipophilicity, vary [4] . PET is a sensitive marker of metabolic activity in atherosclerotic lesions; this is primarily attributed to inflammation [13, 15] . Statins have been shown to exert many anti-inflammatory cellular effects [4, 9] and to reduce [
18 F]FDG uptake in humans [13] . Although it is likely that there are pro-inflammatory pathways in macrophages that are not directly reflected by [
18 F]FDG uptake [9] , it did correlate with plasma cholesterol levels and with the quantity of macrophages in plaques in our study. In line with our results, prolonged atorvastatin therapy in apolipoprotein E-deficient mice with a mutation in the fibrillin-1 gene had no effect on plaque macrophage content despite reduced systemic inflammatory markers [10] . However, in that model statin reduced other features of plaque vulnerability, such as fibrous cap thickness, metalloproteinase activity and pro-inflammatory cytokine expression in the absence of cholesterollowering [10] . Thus, more studies are needed to understand the significance of various potential cholesterol-independent anti-inflammatory and plaque-stabilizing effects of statins. 
15 CT protocol was, however, considered too risky for the animals due to large amount of contrast agent and high radiation exposure. Due to prolonged duration of HFD, there was extensive atherosclerosis throughout the aorta, and finding lesion-free vessel wall areas was challenging. Thus, both total [ 18 F]FDG uptake in plaques and relative uptake (plaque-to-wall ratio) were measured. Limited sample size precludes detection of small differences between treatments that might still be significant in long-term disease progression.
Due to limited responsiveness of Ldlr -/-Apob 100/100 mice to statins, similar studies in other animal models are
warranted to obtain further information on the effects of statins on vascular inflammation.
Oral atorvastatin intervention showed no significant effect on inflammation in the atherosclerotic Ldlr 
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